Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. [electronic resource]

By: Contributor(s): Producer: 20120919Description: 310-7 p. digitalISSN:
  • 1592-8721
Subject(s): Online resources: In: Haematologica vol. 97
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study

There are no comments on this title.

to post a comment.